GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ABCG2 | 74 | LTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.1739 | 21618577
|
GPC3 | 4451 | LTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.0032 | 21618577
|
KIT | 6342 | LTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.018 | 21618577
|
NANOG | 20857 | LTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.5461 | 21618577
|
POU5F1 | 9221 | LTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.6448 | 21618577
|
PROM1 | 9454 | LTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.7582 | 21618577
|
SOX2 | 11195 | LTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and qRT-PCR | NA | 0.2 | 0.5695 | 21618577
|
AAMP | 18 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ABCB1 | 40 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0604 | 21618577
|
ABHD8 | 23759 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ACOT11 | 18156 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ACTN4 | 166 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
ADAM17 | 195 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ADAM22 | 201 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ADAMTS1 | 217 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
ADAMTSL3 | 14633 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
AGGF1 | 24684 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
AGT | 333 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
AHDC1 | 25230 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
AKAP1 | 367 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
AKR1B10 | 382 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
AKR1C4 | 387 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ALG13 | 30881 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ALKBH8 | 25189 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ALPK2 | 20565 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
AMD1 | 457 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
AMDHD1 | 28577 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
ANKFY1 | 20763 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ANKRD10 | 20265 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ANKRD50 | 29223 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
ANP32A | 13233 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ANXA6 | 544 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
AP2B1 | 563 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
APEH | 586 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
APOBEC3B | 17352 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
APOC1 | 607 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
AR | 644 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ARC | 648 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ARHGAP32 | 17399 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
ARHGEF10 | 14103 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
ARHGEF12 | 14193 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ARHGEF19 | 26604 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ARL9 | 23592 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ARMT1 | 17872 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ARRDC3 | 29263 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ASGR1 | 742 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ASPHD1 | 27380 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ASRGL1 | 16448 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
ATAT1 | 21186 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ATM | 795 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
AXIN2 | 904 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
B4GALT5 | 928 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
BAAT | 932 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
BAX | 959 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
BCAP29 | 24131 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
BCL2L15 | 33624 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
BHLHB2 | 1046 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
BHLHB9 | 29353 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
BOLA1 | 24263 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
BORA | 24724 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
BRWD1 | 12760 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
C10ORF35 | 23519 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
C12ORF34 | 25915 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
C12ORF60 | 28726 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
C15ORF29 | 26199 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
C18ORF54 | 13796 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
C1GALT1 | 24337 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
C1ORF109 | 26039 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
C1ORF54 | 26258 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
C3ORF14 | 25024 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
C3ORF23 | 25241 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
C9ORF152 | 31455 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
CAPN15 | 11182 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CAPRIN2 | 21259 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
CASP1 | 1499 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CAV1 | 1527 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0117 | 21618577
|
CBX3 | 1553 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
CCDC183 | 28236 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CCL20 | 10619 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
CCN3 | 7885 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CCND1 | 1582 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0201 | 21618577
|
CDC2 | 1722 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
CDC34 | 1734 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CDC42BPB | 1738 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
CDC42EP1 | 17014 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CDH15 | 1754 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CDKN1C | 1786 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CDKN2B | 1788 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
CDRT4 | 14383 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CEBPD | 1835 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
CELSR2 | 3231 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
CENPA | 1851 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
CFAP53 | 26530 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CGN | 17429 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
CHAC2 | 32363 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
CHPT1 | 17852 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
CHST13 | 21755 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CITED1 | 1986 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
CKAP2 | 1990 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CKAP2L | 26877 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
CLDN15 | 2036 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CLDN2 | 2041 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
CLRN3 | 20795 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CNOT6 | 14099 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
COL15A1 | 2192 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
COL18A1 | 2195 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
COL4A5 | 2207 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
COMMD8 | 26036 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
COPZ2 | 19356 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
COX11 | 2261 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
COX19 | 28074 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
CPEB2 | 21745 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
CSF2RA | 2435 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CSGALNACT1 | 24290 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
CSPP1 | 26193 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CTAG2 | 2492 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CTRL | 2524 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CUTC | 24271 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
CX3CL1 | 10647 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
CXCL2 | 4603 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
CYP3A5 | 2638 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
CYSRT1 | 30529 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
DAPK1 | 2674 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
DBF4 | 17364 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
DCAF13 | 24535 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
DCLRE1B | 17641 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
DDIT4 | 24944 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
DDR1 | 2730 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
DDR2 | 2731 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
DENND5B | 28338 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
DFFA | 2772 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
DGCR8 | 2847 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
DHRS1 | 16445 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
DIPK2A | 28490 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
DLEU1 | 13747 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
DMBT1 | 2926 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
DNPH1 | 21218 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
DTL | 30288 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
DTNA | 3057 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
DUSP10 | 3065 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
DYNC1H1 | 2961 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
DYNC1LI1 | 18745 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
DYNC2I1 | 21862 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ECM2 | 3154 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
EDARADD | 14341 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
EDN1 | 3176 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
EDN2 | 3177 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
EEA1 | 3185 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
EEF1A2 | 3192 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
EEF2K | 24615 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
EHF | 3246 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
EIF2B4 | 3260 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
EIF4E | 3287 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ELFN2 | 29396 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ELFN2 | 29396 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ELP1 | 5959 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
EMG1 | 16912 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ENKD1 | 25246 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
EP400 | 11958 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
EPGN | 17470 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
EPM2AIP1 | 19735 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ERN1 | 3449 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ESAM | 17474 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
EVA1A | 25816 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
EXPH5 | 30578 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
F8A1 | 3547 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
F8A1 | 31849 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
F8A1 | 31850 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
FABP6 | 3561 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
FAHD2A | 24252 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
FAM102B | 27637 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
FAM167A | 15549 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
FAM69B | 28290 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
FAM72D | 33593 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
FAM81A | 28379 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
FAM83B | 21357 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
FAM98B | 26773 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
FBXO32 | 16731 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
FCHO1 | 29002 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
FES | 3657 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
FGD3 | 16027 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
FGF13 | 3670 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
FGF2 | 3676 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
FGG | 3694 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
FHDC1 | 29363 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
FKBP4 | 3720 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
FKBP4 | 13949 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
FLRT3 | 3762 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
FMO3 | 3771 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
FOLR1 | 3791 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
FOXA2 | 5022 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
FSD1 | 13745 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GALNT11 | 19875 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
GAS2L3 | 27475 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GATA2 | 4171 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GBP2 | 4183 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GCNT3 | 4205 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GDA | 4212 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
GHR | 4263 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GKAP1 | 17496 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GLB1 | 4298 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GLRX3 | 15987 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
GLT8D2 | 24890 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GMIP | 24852 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GMPPB | 22932 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
GNAL | 4388 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
GNGT1 | 4411 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GNPTG | 23026 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
GNRH1 | 4419 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
GPR87 | 4538 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
GPX3 | 4555 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
GRIK2 | 4580 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
GSG1L | 28283 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
GSPT2 | 4622 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
GTF2H2 | 4656 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GTF2H2 | 31394 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
GTPBP8 | 25007 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
GUSB | 4696 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
H19 | 4713 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
H2AC8 | 4724 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HABP2 | 4798 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
HADH | 4799 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HADHA | 4801 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
HAUS1 | 25174 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
HCG27 | 27366 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HCG9 | 21243 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HERC2 | 4868 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HIKESHI | 26938 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HJURP | 25444 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
HLA-DMA | 4934 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
HLA-F | 4963 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HLA-G | 4964 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
HMGCR | 5006 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
HMGCS1 | 5007 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
HNRPLL | 25127 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HOMER3 | 17514 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HOXA13 | 5102 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HOXC9 | 5130 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
HRK | 5185 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HRSP12 | 16897 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
HS1BP3 | 24979 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HSCB | 28913 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
HSPE1 | 5269 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
ICAM1 | 5344 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
IER3 | 5392 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
IFI16 | 5395 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
IFI6 | 4054 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
IFITM1 | 5412 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
IL24 | 11346 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
IL6 | 6018 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0191 | 21618577
|
IL8 | 6025 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0159 | 21618577
|
ING2 | 6063 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
INHBB | 6067 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
INHBE | 24029 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
INTS13 | 20174 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
INTS3 | 26153 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
INTS6 | 14879 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ITGA6 | 6142 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0265 | 21618577
|
ITGB5 | 6160 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
ITSN2 | 6184 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
IVNS1ABP | 16951 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
KBTBD8 | 30691 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
KCNH2 | 6251 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
KIAA0256 | 28997 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
KIAA2026 | 23378 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
KIF1B | 16636 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
KIFAP3 | 17060 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
KLF9 | 1123 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
KLHL11 | 19008 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
KLHL15 | 29347 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
KLHL23 | 27506 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
KLKB1 | 6371 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
KMT2C | 13726 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
KNSTRN | 30767 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
KRT16 | 6423 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
KRT19 | 6436 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
KRTDAP | 16313 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
LAMA1 | 6481 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
LDAF1 | 30136 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
LGR4 | 13299 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
LHX4 | 21734 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
LIG1 | 6598 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
LIPT1 | 29569 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
LRBA | 1742 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
LRCH1 | 20309 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
LRIG1 | 17360 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
LRMDA | 23405 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
LRRC45 | 28302 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
LSM5 | 17162 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
LSM6 | 17017 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
LSS | 6708 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
LTO1 | 17589 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
LYPD6 | 28751 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MAF | 6776 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MAFB | 6408 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
MAGEA1 | 6796 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MAP3K4 | 6856 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MAP3K8 | 6860 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
MAP7D2 | 25899 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
MAPK8 | 6881 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
MAPKAPK3 | 6888 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
MARK2 | 3332 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MATK | 6906 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
MB21D2 | 30438 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
MBD2 | 6917 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MBTPS1 | 15456 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MC1R | 6929 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MCFD2 | 18451 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MCTP1 | 26183 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MDN1 | 18302 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
ME1 | 6983 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
MED12 | 11957 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MED21 | 11473 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MED9 | 25487 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MEMO1 | 14014 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
METTL5 | 25006 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
METTL6 | 28343 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MFNG | 7038 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MGARP | 29969 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MIX23 | 31136 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MMP23B | 7171 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MMP25 | 14246 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MND1 | 24839 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MPHOSPH6 | 7214 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MPI | 7216 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
MPP7 | 26542 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
MPV17 | 7224 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MRPL33 | 14487 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MRPL47 | 16652 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MRPL48 | 16653 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MSRB3 | 27375 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MTHFD2 | 7434 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
MXD1 | 6761 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MYO9A | 7608 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
MYPN | 23246 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
MYRF | 1181 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
N4BP1 | 29850 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NAB1 | 7626 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NACA4P | 24688 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NCOA2 | 7669 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
NDUFAF4 | 21034 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NDUFS6 | 7713 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NEURL4 | 34410 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
NF1 | 7765 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
NFIB | 7785 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
NIBAN1 | 16784 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
NME6 | 20567 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NMRK1 | 26057 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NMRK2 | 17871 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NOD1 | 16390 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NOG | 7866 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NOL12 | 28585 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NPNT | 27405 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
NPTX1 | 7952 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
NR2F2 | 7976 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NR4A1 | 7980 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
NRTN | 8007 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NSUN6 | 23529 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
NUAK2 | 29558 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NUDT6 | 8053 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
NUP214 | 8064 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
NUP35 | 29797 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
OLR1 | 8133 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
ORM1 | 8498 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ORMDL1 | 16036 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
OSCP1 | 29971 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
OTUD4 | 24949 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
P2RY11 | 8540 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PAK1IP1 | 20882 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PAQR5 | 29645 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
PAQR9 | 30131 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PARP4 | 271 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PAX9 | 8623 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PBX1 | 8632 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
PCCA | 8653 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PCDH20 | 14257 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
PCDHB17P | 14547 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PCDHB2 | 8687 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PCDHB2 | 8688 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PCGF6 | 21156 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PCSK6 | 8569 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PDE7B | 8792 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PDGFRA | 8803 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PDZD2 | 18486 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
PEA15 | 8822 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PFN2 | 8882 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PGM2L1 | 20898 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PLAC8 | 19254 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PLCXD3 | 31822 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PMAIP1 | 9108 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PNPLA7 | 24768 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
POLR1G | 24219 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
POLR3C | 30076 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
POLR3G | 30075 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
POM121 | 19702 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PPIP5K1 | 29023 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PPP1R15A | 14375 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PPP1R3C | 9293 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
PPP2R2D | 23732 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PROSER2 | 23728 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
PRRX1 | 9142 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
PRSS53 | 34407 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PRTFDC1 | 23333 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
PSCA | 9500 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
PSMC6 | 9553 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
PSTK | 28578 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
PYROXD2 | 23517 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
R3HDM1 | 9757 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RAB11A | 9760 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RAB3IL1 | 9780 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
RAB40B | 18284 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RAB6A | 9786 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RAPGEF6 | 20655 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RBBP6 | 9889 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
REEP2 | 17975 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
REV3L | 9968 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
REXO4 | 12820 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RFESD | 29587 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RFPL3S | 9981 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RGR | 9990 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RGS12 | 9994 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RHBDF2 | 20788 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RHOB | 668 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
RICTOR | 28611 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RILPL1 | 26814 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RIPK3 | 10021 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RIPK4 | 496 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
RIPOR1 | 25836 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RN7SK | 10037 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
RNASEH1 | 18466 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RNASEH2B | 25671 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RNASEH2C | 24116 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
RND1 | 18314 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
RNF111 | 17384 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
RNF125 | 21150 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
RNF144B | 21578 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
RNF149 | 23137 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
RNFT1 | 30206 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RNLS | 25641 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RPL36A | 10359 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RPL6 | 10362 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
RPS7 | 10440 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
RRAGB | 19901 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RRM2 | 10452 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
RRP9 | 16829 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
RTL8C | 2569 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
RUNX1 | 10471 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
S100A7L2 | 21655 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SC5DL | 10547 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SCIN | 21695 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
SCNN1D | 10601 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SEC16A | 29006 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SECISBP2 | 30972 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SELL | 10720 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SERPINE1 | 8583 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
SERTAD4 | 25236 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SESN1 | 21595 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SF3B6 | 30096 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SFXN2 | 16086 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SGSH | 10818 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SH2D4A | 26102 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
SH3BGRL2 | 15567 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SH3BP5L | 29360 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SHOC1 | 26535 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SHPK | 1492 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SKAP2 | 15687 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SLC17A3 | 10931 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SLC22A23 | 21106 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SLC25A19 | 14409 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SLC35F6 | 26055 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SLC39A8 | 20862 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SLC47A1 | 25588 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
SLC49A4 | 16628 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SLC6A12 | 11045 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
SLC7A8 | 11066 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
SLC9B2 | 25143 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SMAD6 | 6772 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
SMAP1 | 19651 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SMC1A | 11111 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SMG9 | 25763 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SNAI2 | 11094 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0159 | 21618577
|
SNAP23 | 11131 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SND1 | 30646 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SND1-IT1 | 24158 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SNHG5 | 21026 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SNORA25 | 32615 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SNX24 | 21533 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SOCS4 | 19392 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SOX4 | 11200 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
SOX9 | 11204 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0244 | 21618577
|
SPAG1 | 11212 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SPATA2 | 14681 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SPG11 | 11226 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SPRR1B | 11260 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
SPRY4 | 15533 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SPTSSA | 20361 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
SPTSSB | 24045 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SRPK2 | 11306 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SSH2 | 30580 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
SSX1 | 11335 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
STEAP2 | 17885 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
STX11 | 11429 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
SYNGR4 | 11502 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TAF1A | 11532 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TAF5L | 17304 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TAF9 | 11542 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TAS2R14 | 14920 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
TAS2R5 | 14912 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TATDN1 | 24220 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TATDN3 | 27010 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TAX1BP3 | 30684 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TCEA3 | 11615 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TDP2 | 17768 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TENT5A | 18345 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TFF2 | 11756 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TFF3 | 11757 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0042 | 21618577
|
TFR2 | 11762 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TICRR | 28704 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TIMP4 | 11823 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TLE6 | 30788 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TM4SF5 | 11857 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TMBIM1 | 23410 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TMED10 | 16998 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TMEM126B | 30883 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TMEM128 | 28201 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TMEM131L | 29146 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TMEM256 | 28618 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TMEM268 | 24513 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TMEM79 | 28196 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TNFAIP3 | 11896 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0064 | 21618577
|
TNFRSF11B | 11909 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
TNFRSF12A | 18152 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TNFRSF13C | 17755 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TNIK | 30765 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0053 | 21618577
|
TNKS1BP1 | 19081 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TOX2 | 16095 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TPP1 | 2073 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TPR | 12017 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
TPRKB | 24259 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TPST1 | 12020 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TRAF7 | 20456 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TRAPPC2 | 23068 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TRIM29 | 17274 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0074 | 21618577
|
TRIM37 | 7523 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TRIM4 | 16275 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TRIM7 | 16278 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TRMT61B | 26070 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TRPV2 | 18082 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TSPAN10 | 29942 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TTC12 | 23700 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TTC27 | 25986 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TTC3 | 12393 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TTLL3 | 24483 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
TXNDC16 | 19965 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
TXNDC9 | 24110 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
TYSND1 | 28531 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
UBA2 | 30661 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
UBAP2L | 29877 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
UBE2Q2 | 19248 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
UBE3D | 21381 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
UBXN2A | 27265 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
UCN | 12516 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
UGT1A1 | 12530 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
UGT1A10 | 12531 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
UMPS | 12563 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
UQCR11 | 30862 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
VAMP1 | 12642 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
VCX3B | 31838 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
VGF | 12684 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
VPS37D | 18287 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
VRK2 | 12719 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
VWA1 | 30910 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
WEE1 | 12761 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
YPEL2 | 18326 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
YTHDC1 | 30626 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZBTB20 | 13503 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZBTB5 | 23836 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZBTB8OS | 24094 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZC3H12A | 26259 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZC3H8 | 30941 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZCWPW1 | 23486 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZFC3H1 | 28328 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZFYVE21 | 20760 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZFYVE26 | 20761 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF121 | 12904 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF140 | 12925 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
ZNF17 | 12958 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF271P | 13065 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF295-AS1 | 23130 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF304 | 13505 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZNF324 | 14096 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF33B | 13097 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZNF35 | 13099 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF385B | 26332 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF397 | 18818 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
ZNF417 | 20646 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF443 | 20878 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF543 | 25281 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZNF580 | 29473 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF581 | 25017 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF585A | 26305 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZNF627 | 30570 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZNF630 | 28855 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZNF671 | 26279 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZNF695 | 30954 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0021 | 21618577
|
ZNF740 | 27465 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF75A | 13146 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0032 | 21618577
|
ZNF771 | 29653 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF777 | 22213 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF784 | 33111 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF805 | 23272 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF81 | 13156 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZNF875 | 4928 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|
ZP3 | 13189 | HTM | Hepatic Cancer | NA | WRL68 | Zebularine | SP assay followed by SFA and Transcriptomics | Up | 0.04 | 0.0011 | 21618577
|